Rosen Health Institute of Canada

Rosen Health Research Institute of Canada is one of the most famous medical research centers in the world. Sy-005 (recombinant human annexin A5) developed by Suzhou Yabao in cooperation with Rosen Health Research Institute of Canada belongs to the first in class drug in the world, and the treatment indication is sepsis. At present, the product has launched Global Multi Center Phase II clinical research at home and abroad.

Next:Nothing